Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Apr 6, 2025

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

This is interesting and important. The bottom line: If you are getting treated for wet AMD and stop going to follow-ups, you are proven not to do as well as…

Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up

Mar 31, 2025

The Aira App: On Demand Expert Assistance

With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your smartphone, they walk you through whatever task you’re struggling to…

The Aira App: On Demand Expert Assistance

Mar 26, 2025

Researchers develop eye drops that slow progressive vision loss in mice

March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, to administer to mice in the form of a drop…

Researchers develop eye drops that slow progressive vision loss in mice

Mar 24, 2025

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, 2025, at 12 PM EDT Duration: 1 hour Learn how…

Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management

Mar 24, 2025

Retinal vein occlusion (RVO) patients to participate in a paid market research study

      Opinions Link Research is looking for retinal vein occlusion (RVO) patients to participate in a paid market research study, sharing their opinions on this condition and treatments taken…

Retinal vein occlusion (RVO) patients to participate in a paid market research study

Mar 24, 2025

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

March 20, 2025, By Jordana Joy, Associate Editor Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline in the severity of overall dry…

Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED

Mar 18, 2025

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

New Research Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain inChildren: A Randomized Double‑Blind Placebo‑Controlled Trial Karen A.  Hecht· Megha Marwah· Vincent Wood· Yasuhiro Nishida· Austin E. Bach· Jeffry…

Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial

Mar 18, 2025

Cigarette smoking linked to reduced choroidal vascularity

Author(s): Lynda Charters Key Takeaways Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI). Smoking increases oxidative stress, affecting vascular endothelium and reducing retinal…

Cigarette smoking linked to reduced choroidal vascularity

Mar 14, 2025

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

By Sarah Caesar | Fact-checked by Barbara Bekiesz | Published March 10, 2025 Industry Buzz “[It’s] important to consider gradually tapering patients onto these drugs. Slowly lowering blood sugar, rather than doing so rapidly, may help reduce…

Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’

Mar 14, 2025

Can Vitamins Help Slow Down Macular Degeneration?

Macular degeneration is a progressive eye condition that has no cure. In some cases, a specific combination of nutrients found in supplements called AREDS 2 can slow its progression. Age-related…

Can Vitamins Help Slow Down Macular Degeneration?

Mar 11, 2025

The human impact of geographic atrophy

Author(s): Ophthalmology Times Staff Reports Fact checked by: Sheryl Stevenson Key Takeaways GA significantly impacts patients’ independence, with many reducing activities like driving and hobbies, affecting their sense of self…

The human impact of geographic atrophy

Mar 10, 2025

Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

Author(s): Martin David Harp Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of a proprietary expression cassette and is designed to be administered…

Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD

Mar 4, 2025

Astaxanthin (AstaReal®) Improved Acute andChronic Digital Eye Strain inChildren: ARandomized Double‑Blind Placebo‑Controlled Trial

“Our very own medical director, Dr. Jeffry Gerson, is involved with eyecare beyond macular degeneration.”  See the latest publication he has been working on: ABSTRACT Introduction: This study assessed the…

Astaxanthin (AstaReal®) Improved Acute andChronic Digital Eye Strain inChildren: ARandomized Double‑Blind Placebo‑Controlled Trial

Mar 4, 2025

GA lesion location plays role in vision-related quality of life

By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: Vision-related quality of life is primarily dependent on the eye with better vision. An analysis found the inner lower…

GA lesion location plays role in vision-related quality of life

Mar 4, 2025

Older patients with DME have weaker response to anti-VEGF treatment

By: Alex Young Fact checked by: Christine Klimanskis, ELS Key takeaways: Improvement in visual acuity and central subfield thickness from baseline decreased with older age. Weak treatment response in both…

Older patients with DME have weaker response to anti-VEGF treatment

Mar 3, 2025

“Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy”

Principal Investigator: Jeremiah Brown, Jr., MS, MD It is notable that the rate of progression of geographic atrophy varies amongst patients, amongst lesion types, and amongst lesion patterns.  Some patients are…

“Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy”

Mar 3, 2025

Food as medicine: The role of nutrition in eye health

March 3, 2025 By Carrie Roitstein, OD, cPNP, INHC Fact checked by Jordana Joy, Associate Editor Creating a healthier population will require extended efforts by optometrists. The idea of using food as…

Food as medicine: The role of nutrition in eye health

Feb 18, 2025

Moderate to severe obstructive sleep apnea tied to higher odds for neovascular AMD

By: Cassandra Jenkins Fact checked by: Heather Biele Key takeaways: Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD. Nocturnal hypoxia may be a…

Moderate to severe obstructive sleep apnea tied to higher odds for neovascular AMD

Feb 17, 2025

COPHy The 16th Annual Congress on Controversies in Ophthalmolgy

COPHy VOD Unlock unparalleled access to the world of ophthalmology! ComtecMed VOD platform is your gateway to the exclusive annual World Congress on Controversies in Ophthalmology (COPHy). With lectures and debates…

COPHy The 16th Annual Congress on Controversies in Ophthalmolgy

Feb 17, 2025

MIND diet ranked no. 1 for brain health

Published February 3, 2025 | Originally published on Newswise: Health Food A diet created by researchers at Rush is ranked among the top diets for 2025 by U.S. News & World Report. Best Diets…

MIND diet ranked no. 1 for brain health

Feb 14, 2025

FDA approves amended label for Izervay for geographic atrophy

February 13, 2025 By Emily Kaiser Maharjan, Assistant Managing Editor The approval follows a refiling after the FDA issued a Complete Response Letter regarding language on the amended label. The FDA…

FDA approves amended label for Izervay for geographic atrophy

Feb 11, 2025

Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg

February 10, 2025, By Martin David Harp Results were published from the phase 3 QUASAR trial and the extension study of the phase 3 PULSAR trial. Regeneron Pharmaceuticals has announced results…

Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg

Feb 11, 2025

February is Low Vision Awareness Month

Did you know that?  Statistics show that low vision affects 2.2 billion people globally, and 12 million in the US, impacting their daily lives. Low Vision can result due to…

February is Low Vision Awareness Month

Feb 10, 2025

Federal Policy Announcements and Discussions about Funding Research

    Dear Macular Degeneration Association Friends, The recent federal policy announcements and discussions about funding research have raised questions from our donors about the potential impact on biomedical research.…

Federal Policy Announcements and Discussions about Funding Research

Feb 10, 2025

February is Macular Degeneration Awareness Month

Here is important information about macular degeneration, which is known as the number one cause of irreversible blindness and visual impairment in the older population. Age-related macular degeneration (AMD) is…

February is Macular Degeneration Awareness Month

Feb 4, 2025

Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system

    Author(s): Martin David Harp Key Takeaways The AI algorithm demonstrated strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces in nAMD patients. The AI’s repeatability in…

Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system

Feb 4, 2025

February is Age-Related Macular Degeneration Month

            February is Age-Related Macular Degeneration (AMD) Awareness Month Did you know that there are three forms of age-related macular degeneration? Dry AMD is a…

February is Age-Related Macular Degeneration Month

Feb 4, 2025

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy- Research project funded by the Macular Degeneration Association Principal Investigator: …

Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy

Feb 3, 2025

Intracranial pressure levels may be a critical factor in glaucoma

Key takeaways: Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis,…

Intracranial pressure levels may be a critical factor in glaucoma

Jan 31, 2025

Opening our eyes to the impact of preservatives

January 30, 2025 By Elyse Rayborn, OD, MBA, FAAO Chris Lievens, OD, MS, FAAO, FNAP Optometry Times JournalJanuary/February digital edition 2025 Preservatives may disrupt the ocular surface, contributing to poor adherence.…

Opening our eyes to the impact of preservatives

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.